The Prescription Drugs (Pharmacies) market in CIS is experiencing significant growth and development due to a combination of customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. Customer preferences in the Prescription Drugs (Pharmacies) market in CIS are driving the demand for a wide range of prescription drugs. Customers are increasingly seeking convenience and accessibility when it comes to purchasing their medications. This has led to a rise in the number of pharmacies and the expansion of their services. Customers are also becoming more health-conscious and are willing to spend more on prescription drugs to improve their well-being. Additionally, there is a growing demand for specialized prescription drugs, such as those for chronic diseases and mental health conditions. Trends in the market are also contributing to the development of the Prescription Drugs (Pharmacies) market in CIS. One major trend is the increasing use of e-commerce and online platforms for purchasing prescription drugs. This allows customers to conveniently order their medications from the comfort of their homes and have them delivered directly to their doorstep. Another trend is the expansion of pharmacy chains, which are able to offer a wider range of prescription drugs and services compared to independent pharmacies. These chains are also investing in technology and automation to improve efficiency and customer experience. Local special circumstances in CIS countries are influencing the development of the Prescription Drugs (Pharmacies) market. Each country has its own healthcare system and regulations, which can impact the availability and accessibility of prescription drugs. Some countries have a higher prevalence of certain diseases, leading to a higher demand for specific medications. Additionally, the aging population in many CIS countries is driving the need for prescription drugs for age-related conditions. Underlying macroeconomic factors are also playing a role in the development of the Prescription Drugs (Pharmacies) market in CIS. Economic growth and increasing disposable incomes are allowing more people to afford prescription drugs. Government initiatives to improve healthcare access and affordability are also driving the demand for prescription drugs. Furthermore, the increasing prevalence of chronic diseases and the need for long-term medication are contributing to the growth of the market. Overall, the Prescription Drugs (Pharmacies) market in CIS is developing rapidly due to customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. The demand for prescription drugs is expected to continue growing as customers prioritize convenience, health, and well-being. The market is also likely to see further expansion of e-commerce platforms, pharmacy chains, and specialized prescription drugs. The development of the market will be influenced by the unique circumstances and regulations in each CIS country, as well as the overall macroeconomic environment.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
